PLoS By Category | Recent PLoS Articles

Biochemistry - Critical Care and Emergency Medicine - Molecular Biology - Physiology

Cardio-Protection of Salvianolic Acid B through Inhibition of Apoptosis Network
Published: Tuesday, September 06, 2011
Author: Lingling Xu et al.

by Lingling Xu, Yanping Deng, Lixin Feng, Defang Li, Xiaoyan Chen, Chao Ma, Xuan Liu, Jun Yin, Min Yang, Fukang Teng, Wanying Wu, Shuhong Guan, Baohong Jiang, Dean Guo

Targeting cellular function as a system rather than on the level of the single target significantly increases therapeutic potency. In the present study, we detect the target pathway of salvianolic acid B (SalB) in vivo. Acute myocardial infarction (AMI) was induced in rats followed by the treatment with 10 mg/kg SalB. Hemodynamic detection and pathological stain, 2-dimensional electrophoresis, MALDI-TOF MS/MS, Western blot, pathway identification, apoptosis assay and transmission electron microscope were used to elucidate the effects and mechanism of SalB on cardioprotection. Higher SalB concentration was found in ischemic area compared to no-ischemic area of heart, correlating with improved heart function and histological structure. Thirty-three proteins regulated by SalB in AMI rats were identified by biochemical analysis and were classified as the components of metabolism and apoptosis networks. SalB protected cardiomyocytes from apoptosis, inhibited poly (ADP-ribose) polymerase-1 pathway, and improved the integrity of mitochondrial and nucleus of heart tissue during AMI. Furthermore, the protective effects of SalB against apoptosis were verified in H9c2 cells. Our results provide evidence that SalB regulates multi-targets involved in the apoptosis pathway during AMI and therefore may be a candidate for novel therapeutics of heart diseases.